Ocean Biomedical, Inc.

Business Description

Ocean Biomedical, formed in 2019, and based out of Rhode Island, U.S., is a biopharma company that went public through a reverse merger of Aesther Healthcare Acquisition Corp. – a Special Purpose Acquisition Company (“SPAC”) formed to acquire a company seeking to go public. SPACs gained popularity in 2020/2021 as a faster/cheaper route for private companies to go public.

Website https://www.oceanbiomedical.com/

FRC Analyst's Reports

Ocean Biomedical Inc. (NASDAQ: OCEA) – An Incubator with Potential Treatments for Cancer, Malaria and Fibrosis – Initiating Coverage	Mar. 15, 2023
Ocean Biomedical Inc. (NASDAQ: OCEA) – An Incubator with Potential Treatments for Cancer, Malaria and Fibrosis – Introductory Note	Feb. 23, 2023